GSK halts new clinical trials in Russia but continues supply of medicines
GlaxoSmithKline (GSK) has said it will keep supplying essential medicines in Russia but will halt new clinical trials due to the invasion of Ukraine.
Full Article
GSK halts new clinical trials in Russia but continues supply of medicines
Belfast Telegraph
0 shares
1 views
You might like
Related news coverage
Medicine market in Russia ‘stable’ as GSK commits to keeping up supply
GlaxoSmithKline’s (GSK) will halt clinical trials in Russia but maintain the supply of essential medicines, following the..
City A.M.